Zelluna ASA (OSTO:ULTIO) EPS without NRI: kr-5.90 (TTM As of Mar. 2026)


OSTO:ULTIO Zelluna ASA OSTO:ULTIO
28 GF Score
Price kr21.95
! 2 Warning Signs
View Full Analysis

What is Zelluna ASA EPS without NRI?

Zelluna ASA OSTO:ULTIO 28 EPS without NRI is kr-5.90 as of Mar. 2026. GuruFocus rates OSTO:ULTIO with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 1,166 Biotechnology companies, Zelluna ASA ranks better than 83.62% on this metric.

Zelluna ASA's earnings per share without non-recurring items for the three months ended in Mar. 2026 was kr-0.80. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was kr-5.90.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 48.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 33.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Zelluna ASA's EPS without NRI or its related term are showing as below:

OSTO:ULTIo' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -23.5   Med: -13.6   Max: 48
Current: 48

During the past 11 years, Zelluna ASA's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 48.00% per year. The lowest was -23.50% per year. And the median was -13.60% per year.

OSTO:ULTIo's 3-Year EPS without NRI Growth Rate is ranked better than
83.62% of 1166 companies
in the Biotechnology industry
Industry Median: 16.4 vs OSTO:ULTIo: 48.00

Zelluna ASA's EPS (Diluted) for the three months ended in Mar. 2026 was kr-0.80. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-6.00.

Zelluna ASA's EPS (Basic) for the three months ended in Mar. 2026 was kr-0.80. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-6.00.


Zelluna ASA  (OSTO:ULTIo) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Zelluna ASA EPS without NRI Related Terms


Zelluna ASA EPS without NRI Historical Data

* Premium members only.

The historical data trend for Zelluna ASA's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zelluna ASA EPS without NRI Chart

Zelluna ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -50.54 -50.48 -58.70 -7.10 -7.10

Zelluna ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.40 -1.80 -1.90 -1.40 -0.80

OSTO:ULTIO vs VRTX, REGN, ALNY: EPS without NRI Comparison

For the Biotechnology subindustry, Zelluna ASA's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zelluna ASA PE Ratio without NRI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zelluna ASA's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Zelluna ASA's PE Ratio without NRI falls into.


OSTO:ULTIO
28GF Score
Zelluna ASA OSTO:ULTIO
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zelluna ASA EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-5.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of kr-5.90 mean?
Zelluna ASA (OSTO:ULTIO) has a EPS without NRI of kr-5.90 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Zelluna ASA and its competitors. According to the industry distribution chart, Zelluna ASA ranks #191 out of 1166 companies in the Biotechnology industry, placing it in the top 16.4%.
Is Zelluna ASA's EPS without NRI too high?
Zelluna ASA's current EPS without NRI is kr-5.90. Based on the distribution chart, Zelluna ASA ranks #191 out of 1166 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Zelluna ASA has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Zelluna ASA's EPS without NRI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Zelluna ASA ranks #191 out of 1166 companies for EPS without NRI. This places Zelluna ASA in the top 16% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 16.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Biotechnology company?
The median EPS without NRI among Biotechnology companies is 16.40, based on 1,166 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Zelluna ASA and its competitors. For the Biotechnology industry, the median EPS without NRI is 16.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zelluna ASA's current EPS without NRI is kr-5.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zelluna ASA stock overvalued right now?
Zelluna ASA (OSTO:ULTIO) has a current EPS without NRI of kr-5.90. The current EPS without NRI is kr-5.90. Zelluna ASA's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Zelluna ASA (OSTO:ULTIO), the current EPS without NRI is kr-5.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zelluna ASA Business Description

Other Exchanges ZLNA:Norway7UM0:Germany
Address Ullernchausseen 64, Oslo Cancer Cluster Innovation Park, Oslo, NOR, 0379
Zelluna ASA is a biotechnology company established to eliminate solid cancers by unleashing the powerful elements of the immune system through pioneering the development of T cell receptor (TCR) guided natural killer (NK) cell therapies (TCR-NK). Its TCR-NK products are composed of healthy donor-derived NK cells that are genetically engineered to express a tumour-specific TCR that enable the TCR-NK cells to identify and eliminate cancer cells in the body of the patient. Its programme ZI-MA4-1, the first MAGE-A4-targeting TCR-NK therapy for solid tumours with high unmet medical need. Its other programmes include ZI-KL1-1, and ZI-PR-1.
28GF Score

Get the complete analysis for OSTO:ULTIO

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr21.95
Price